Alteogen Signs Exclusive Hyaluronidase License Deal Worth Up to $365 Million
DART
Alteogen Inc.
Filed Aug 5, 2026 KST · Filing
· receipt 20260805900010
kstock has not written this one up.
The title above is a translation of the Korean form name; the filing itself is on DART, in
Korean.
Read the original on DART ↗Korean. DART is Korea's electronic disclosure system, run by the Financial Supervisory
Service — the filing equivalent of EDGAR.
Korean form name: 투자판단관련주요경영사항 (재조합 인간 히알루로니다제 제품 ALTB4 독점적 라이선스 계약 체결)